样式: 排序: IF: - GO 导出 标记为已读
-
Improved Compliance of Daily Sunscreen Application Through a Simple, Daily, Goal‐Setting Reminder: A Randomized Controlled Trial Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-09-19 Steven Q. Wang, Ethan D. Paliwoda, Elle Waske
-
Dermoscopy in Tinea Capitis/Barbae and Tinea of Glabrous Skin: A Comparative Analysis Between Polarized and Ultraviolet‐Induced Fluorescence Examination to Differentiate Microsporum From Trichophyton Infections Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-09-19 Enzo Errichetti, Paweł Pietkiewicz, Natalia Salwowska, Piotr Szlązak, Magdalena Żychowska, Yasmeen J. Bhat
-
Comment on “Impact of Ultraviolet Radiation on Cardiovascular and Metabolic Disorders: The Role of Nitric Oxide and Vitamin D” Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-09-18 S. Tony Wolf, W. Larry Kenney, Nina G. Jablonski
-
Effectiveness of microneedle fractional radiofrequency combined with transcutaneous delivery of botulinum toxin in the management of post‐acne scars Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-09-06 Limin Bai, Gang Xu, Hongmei Ge, Pingsong Li, Qiwen Han, Tuanjie Hou, Ke Lu
BackgroundPost‐acne scars are a common sequela of acne, especially prevalent among young people. Delayed treatment not only affects self‐perception of beauty but also affects the mental health of patients.ObjectiveThis study aims to investigate the clinical efficacy of microneedle fractional radiofrequency (MFR) combined with botulinum toxin A (BoNT/A) in managing post‐acne scars.MethodsThis retrospective
-
How Does Illness Perception Affect the Quality of Life and Sun Protection Behaviors of Rosacea Patients? Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-08-29 Gülfem Akin, Sevgi Akarsu, Ceylan Avcı
BackgroundPrevious studies have noted the link between rosacea severity and quality of life, but there is limited understanding of how disease perception impacts these aspects. Additionally, sun exposure is identified as a common trigger for rosacea flare‐ups, emphasizing the importance of sun protection practices in managing the condition. This cross‐sectional study aims to fill the gap in the literature
-
KGF‐2 ameliorates UVB‐triggered skin photodamage in mice by attenuating DNA damage and inflammatory response and mitochondrial dysfunction Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-08-27 Xuenan Li, Jinli Cheng, Keke Guo, Jianwei Wan, Cuihong Wang, Lu Chen, Nuo Xu, Min Chen
BackgroundLong‐term exposure to UVB induces DNA damage, inflammatory response, mitochondrial dysfunction, and apoptosis in skin cells, thus causing skin photodamage. Research has demonstrated the noteworthy antioxidant, anti‐inflammatory, DNA repair, and mitochondrial protective properties of keratinocyte growth factor‐2 (KGF‐2).MethodsTo examine the impact of KGF‐2 on UVB‐triggered skin photodamage
-
Phototherapy for the treatment of cutaneous graft‐versus‐host disease: A systematic review Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-08-22 Tahel Fachler‐Sharp, Inbar Kobal, Sivan Sheffer‐Levi, Adiel Cohen, Ayal Hassidim, Vered Molho‐Pessach, Rony Shreberk‐Hassidim
BackgroundCutaneous graft‐versus‐host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation. Phototherapy has been used to treat cutaneous GVHD, but data on its safety and efficacy are sparse.AimReview the current medical literature regarding the efficacy, dosing, and safety of various types of phototherapies for the treatment of cutaneous GVHD.MethodsA systematic
-
Sunscreens prescribed to patients with skin of color and/or with melasma: A survey of 221 dermatologists and dermatology residents in Spain Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-08-16 Daniel Morgado‐Carrasco, Jesús Delgado, Ludmila Prudkin‐Silva, Júlia Santamaria, Jaime Piquero‐Casals
BackgroundDark‐skinned individuals (DSI) present high rates of melasma and post‐inflammatory hyperpigmentation. The use of sunscreens with mineral filters is essential for prevention and treatment. Our objective was to determine the preferences of dermatologists and dermatology residents in the prescription of sunscreens for DSI.MethodsAn anonymous survey of attendees at an online photoprotection event
-
Immunofluorescence findings in a reactivating lichenoid photoallergic chronic dermatitis (actinic reticuloid) Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-08-15 Ana Maria Abreu Velez, Mariana Ramírez‐Posada, Michael S. Howard
Background: Chronic photosensitivity dermatitis (CPD) (also named actinic reticuloid) is an unusual disease classically referred often in elderly men. Affected patients have severely itchy, thickened dry skin in areas exposed to the sun throughout the years. Method: A Caucasian female patient who worked most of her life outside who had “chronic dermatitis” in her neck started planting chrysanthemum
-
-
Subjective and objective assessment of color match of universal tinted sunscreens in Fitzpatrick skin phototypes I–VI Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-07-29 Redina Bardhi, Mohsen Mokhtari, Mavra Masood, Deena Abdel‐Gadir, Dorothea McGowan, Olivia Failla, Iltefat H. Hamzavi, Henry W. Lim, Indermeet Kohli, Tasneem F. Mohammad
BackgroundTinted sunscreens not only shield against UV rays but also provide protection against visible light, as opposed to traditional sunscreens. Universal tinted sunscreens are marketed to complement all skin tones.ObjectiveTo assess color match and subject satisfaction for 7 universal tinted sunscreens across various price ranges in all Fitzpatrick skin phototypes (SPT).MethodsProducts A‐G were
-
The efficacy of long‐term psoralen plus ultraviolet A and low‐dose interferon‐a combination therapy in mycosis fungoides: A literature review Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-07-24 Hatice Şanlı, İncilay Kalay Yıldızhan, Kaan Gündüz, Bengü Nisa Akay
Background/PurposeInterferon (IFN)‐a is often used in combination with psoralen plus ultraviolet A (PUVA) in patients with mycosis fungoides (MF) refractory to skin—targeted therapies in early or advanced stages. The main objective is to evaluate the effectiveness of combined PUVA and low‐dose IFN‐α‐2a therapy in patients with early‐ and advanced‐stage MF.MethodsSixty‐eight patients who received a
-
Gliclazide‐induced phototoxicity: A case report Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-07-20 Ankan Gupta, Himadri
-
Modulation of gene expression in skin wound healing by photobiomodulation therapy: A systematic review in vivo studies Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-07-19 Emily Ferreira Salles Pilar, Fernanda Thomé Brochado, Tuany Rafaeli Schmidt, Amanda Costa Leite, Alexia Antunes Deluca, Belkiss Câmara Mármora, Marina Siebert, Vivian Petersen Wagner, Manoela Domingues Martins
BackgroundWound healing is a multistep process involving coordinated responses of a variety of cell types, cytokines, growth factors, and extracellular matrix (ECM) components leading to the physiological restoration of tissue integrity. Photobiomodulation therapy (PBMT) has been highlighted as an approach to improve the healing process, nonetheless at the molecular level, the effects of PBMT are not
-
Skin microbiome profiling reveals the crucial role of microbial metabolites in anti‐photoaging Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-07-05 Ying Li, Huizhen Chen, Xinqiang Xie, Rui Pang, Shixuan Huang, Hang Ying, Moutong Chen, Liang Xue, Jumei Zhang, Yu Ding, Qingping Wu
BackgroundSkin microbiota is essential for health maintenance. Photoaging is the primary environmental factor that affects skin homeostasis, but whether it influences the skin microbiota remains unclear.ObjectiveThe objective of this study is to investigate the relationship between photoaging and skin microbiome.MethodsA cohort of senior bus drivers was considered as a long‐term unilateral ultraviolet
-
Sunproofing from within: A deep dive into oral photoprotection strategies in dermatology. Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-07-01 Dan Hartmann,Fernando Valenzuela
BACKGROUND Photoprotection is the first measure in the prevention and treatment of the deleterious effects that sunlight can cause on the skin. It is well known that prolonged exposure to solar radiation leads to acute and chronic complications, such as erythema, accelerated skin aging, proinflammatory and procarcinogenic effects, and eye damage, among others. METHODS A better understanding of the
-
Evaluation of reflective confocal microscopy in the differential diagnosis of Blaschko‐linear inflammatory skin diseases Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-05-24 Huimin Meng, Cunhuo Jiang, Wenju Wang, Liwen Zhang, Lang Rao, Yan Liu, Yan Cheng
-
Carcinogenic risk in patients treated with UVA‐1 phototherapy: A 5‐year retrospective study Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-05-24 Davide Cosetti, Vittoria Cioppa, Pietro Rubegni, Emanuele Trovato
BackgroundUVA‐1 phototherapy was first used to treat atopic dermatitis and afterwards to several other skin diseases. The contribution of UVA‐1 in human photocarcinogenesis, skin photoaging, immune suppression, and hyperpigmentation is now well established. The actual contribution of UVA‐1 radiation to the development of malignant melanoma (MM) in humans cannot be excluded.PurposeThe aim of the study
-
Usefulness of photodynamic diagnosis for the follow‐up of non‐surgical extramammary Paget's disease Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-05-21 Nerea Mohino‐Farré, Miquel Just‐Sarobé, Jose Antonio Pujol‐Montcusí, Clara Martín‐Callizo, Laia Pastor‐Jané
-
Comparing the efficacy of 308‐nm light‐emitting diode and 308‐nm excimer lamp for treating vitiligo: A randomized controlled trial Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-05-16 Yu Hu, Lihao Liu, Zhuohong Xu, Dan Huang, Hongying Chen, Jiaan Zhang, Lihao Chen, Xiaoxi Dai, Liangliang Zhang, Chao Luan, Mei Ju, Kun Chen
BackgroundIn previous studies, the 308‐nm light‐emitting diode (LED) has been proven safe and effective for treating vitiligo. However, direct comparisons between the 308‐nm LED and 308‐nm excimer lamp (308‐nm MEL) for the treatment of vitiligo are lacking.ObjectiveTo compare the efficacy of the 308‐nm LED and 308‐nm MEL for treating nonsegmental stable vitiligo.Patients and MethodsThis randomized
-
A novel reverse perilesional home phototherapy can promote the repigmentation of vitiligo patches with complete leukotrichia: A 12‐week, open‐label, double‐arm, multicenter, randomized clinical trial Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-05-10 Na Lei, Xuechen Cao, Yifei Feng, Guoyan Liu, Jianqing Feng, Yidong Zhao, Zhiming Zhao, Ziyu Li, Lebin Song, Yan Lu
Background/PurposeExisting phototherapies are ineffective for treating patients with vitiligo with complete leukotrichia. We compared the efficacy of reverse perilesional irradiation, during which only the lesional areas are covered, with conventional narrowband ultraviolet B (NB‐UVB) home phototherapy for repigmentation of non‐segmental vitiligo in patients with complete leukotrichia.MethodsThis was
-
Combination of 308‐nm excimer laser and piperine promotes melanocyte proliferation, migration, and melanin content production via the miR‐328/SFRP1 axis Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-04-30 Yifei Wu, Jiayu Zhang, Sha Du, Xiaochuan Wang, Jinrong Li, Yi Chen, Hongying Zhou, Su Gao, Yongrong Li, Xiuhong Liu
ObjectiveBoth piperine and a 308‐nm excimer laser have significant curative effects on vitiligo. This study mainly explored the molecular mechanism of a 308‐nm excimer combined with piperine in regulating melanocyte proliferation.MethodsEpidermal melanocytes were cultured in piperine solution, and the cells were irradiated by an XTRAC excimer laser treatment system at 308‐nm output monochromatic light
-
Characteristics of dermatology practices accepting Medicaid for phototherapy in the United States: A comprehensive nationwide cross‐sectional analysis Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-04-30 Seda Sahin, Eric J. Beltrami, Hao Feng
-
Inhibition of UVB radiation‐induced tissue swelling and immune suppression by nicotinamide riboside and pterostilbene Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-04-27 Verena Isak, Shayan Azizi, Xi K. Zhou, Devina Mehta, Wanhong Ding, Zakir Bulmer, Daniella S. Aivazi, Ryan W. Dellinger, Richard D. Granstein
BackgroundEnvironmental ultraviolet radiation has deleterious effects on humans, including sunburn and immune perturbations. These immune changes are involved in skin carcinogenesis.ObjectivesTo determine whether nicotinamide riboside and/or pterostilbene administered systemically inhibits inflammatory and immune effects of exposure to mid‐range ultraviolet radiation.MethodsTo examine UVB radiation‐induced
-
Home UVB phototherapy utilization among United States Medicare beneficiaries from 2000 to 2021 Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-04-24 Lisa Kam, Eric Xia, Arash Mostaghimi
-
Lenalidomide‐induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-04-24 Danilo De Novellis, Annunziata Raimondo, Bianca Serio, Carlo Baldi, Valentina Giudice, Serena Lembo, Carmine Selleri
-
Phototherapy for vitiligo: A narrative review on the clinical and molecular aspects, and recent literature Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-04-18 Anuradha Bishnoi, Davinder Parsad
BackgroundVitiligo is characterized by depigmented patches resulting from loss of melanocytes. Phototherapy has emerged as a prominent treatment option for vitiligo, utilizing various light modalities to induce disease stability and repigmentation.Aims and MethodsThis narrative review aims to explore the clinical applications and molecular mechanisms of phototherapy in vitiligo.Results and DiscussionThe
-
Report of a case with CARD14‐associated papulosquamous eruptions and multiple skin cancers Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-04-15 Chia‐Jung Hsu, Tsen‐Fang Tsai
-
Efficacy and safety of excimer light (308 nm) in the treatment of pityriasis lichenoides chronica Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-04-15 Eman Mohamed Salah, Nermeen Ibrahim Bedair, Sarah Khalil Abd El‐Rahim, Mohammed Ahmed El‐Khalawany
IntroductionPityriasis lichenoides chronica is the chronic end of the spectrum of pityriasis lichenoides which have several forms of papulosuamous conditions. Several treatments obtained complete clearance of the condition including phototherapy and specifically narrow band ultraviolet B. The Excimer light 308 is a monochromatic light that acts within the ultraviolet B wavelength and used as a targeted
-
Effect of education on sun‐safe behaviour in kidney transplant recipients Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-04-15 Vanessza Tári, Eszter Anna Janka, Gabriella Emri, Balázs Nemes, Éva Remenyik, Emese Gellén
BackgroundOrgan transplant recipients (OTR) are more likely to develop skin cancer than the general population. One of the main components of the exposome that triggers the development of skin tumours is solar ultraviolet (UV) radiation. To reduce the incidence of harmful consequences of sun exposure, sun protection education is needed for patients taking long‐term immunosuppressive drugs.MethodsIn
-
Phototherapy for pigmentary disorders Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-04-15 Hee Young Kang
CONFLICT OF INTEREST STATEMENT The author declares no conflicts of interest.
-
New trends on personalized sunscreens Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-04-15 Tamara Gracia‐Cazaña, José Aguilera, Alba Navarro‐Bielsa, Salvador González, Henry W. Lim, Yolanda Gilaberte
Background/PurposeNowadays, there are emerging trends in customized and personalized photoprotection, focusing on the innovative approaches to enhance sun protection efficacy tailored to individual needs.MethodsWe conducted an electronic search of the following databases: MEDLINE, EMBASE, Cochrane Database of Systematic Reviews, Cochrane Skin Group Specialised Skin Register, and TESEO. Specific search
-
-
Effect of photodynamic therapy with 5‐aminolevulinic acid and EDTA‐2Na against mixed infection of methicillin‐resistant Staphylococcus aureus and Pseudomonas aeruginosa Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-03-26 Rie Teranishi, Toshiyuki Ozawa, Bunpei Katayama, Yu Shimojo, Nobuhisa Ito, Kunio Awazu, Daisuke Tsuruta
BackgroundThe increasing abundance of drug‐resistant bacteria is a global threat. Photodynamic therapy is an entirely new, non‐invasive method for treating infections caused by antibiotic‐resistant strains. We previously described the bactericidal effect of photodynamic therapy on infections caused by a single type of bacterium. We showed that gram‐positive and gram‐negative bacteria could be killed
-
Analysis of whole blood protoporphyrin and plasma porphyrin in patients on dapsone Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-03-16 Amrutha Haridas, Robert S. Dawe, Victoria A. McGuire
Dapsone is a sulphonamide antibiotic that also has anti-inflammatory effects and is commonly used to treat of a range of dermatological conditions with different causes including dermatitis herpetiformis, pyoderma gangrenosum, Sweet's syndrome, urticarial vasculitis and leprosy.1 Dapsone is known to cause haemolytic anaemia especially in patients with glucose 6-phosphate dehydrogenase (G6PD) deficiency2
-
Phototherapy for vitiligo: Quality and readability of online health information Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-03-16 Krithika Nayudu, Rhea Malik, Stephanie Sanchez‐Melendez, T. J. Hazen, Mihir K. Patil, Vinod E. Nambudiri
Background/PurposeVitiligo is a depigmenting disorder that affects up to 2% of the population. Due to the relatively high prevalence of this disease and its psychological impact on patients, decisions concerning treatment can be difficult. As patients increasingly seek health information online, the caliber of online health information (OHI) becomes crucial in patients' decisions regarding their care
-
Whole‐body and targeted narrowband ultraviolet B phototherapy effectively stabilize acral vitiligo with negligible repigmentation beyond wrists and ankles: Results from a split‐body randomized controlled trial Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-03-14 Anish Thind, Keshavamurthy Vinay, Hitaishi Mehta, Anuradha Bishnoi, Muthu Sendhil Kumaran, Davinder Parsad
BackgroundNarrowband ultraviolet B (NB‐UVB) phototherapy promotes stability and repigmentation in vitiligo. No studies have compared targeted NB‐UVB with whole‐body NB‐UVB in treatment of acral vitiligo.ObjectivesThis randomized split‐body study compared whole‐body NB‐UVB with targeted NB‐UVB in inducing stability and repigmentation in acral vitiligo.MethodsThirty‐two patients with bilaterally symmetrical
-
Efficacy of transcranial photobiomodulation in the treatment for major depressive disorder: A TMS‐EEG and pilot study Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-03-12 Wensi Hao, Xiaona Dai, Min Wei, Siran Li, Mao Peng, Qing Xue, Hua Lin, Huicong Wang, Penghui Song, Yuping Wang
BackgroundMajor depressive disorder (MDD) was a prevalent mental condition that may be accompanied by decreased excitability of left frontal pole (FP) and abnormal brain connections. An 820 nm tPBM can induce an increase in stimulated cortical excitability. The purpose of our study was to establish how clinical symptoms and time‐varying brain network connectivity of MDD were affected by transcranial
-
Five percent 5-aminolevulinic acid photodynamic therapy for the treatment of dissecting cellulitis of the scalp. Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-03-01 Huiying Wang,Ruzhi Zhang
-
Does the risk of basal cell carcinoma increase in patients with psoriasis under treatment? Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-02-26 Gülcan Aliye Sevdem, Kucuk Su Ozlem, Yilmaz Nazan, Onsun Nahide
BackgroundPsoriasis is a common, chronic, inflammatory disease. Although it mainly affects the skin, it has been associated with a large number of comorbidities. In addition to comorbidities such as depression and psoriatic arthritis, it is known that there is an increased prevalence of cancer in psoriasis patients. Skin cancers, particularly squamous cell carcinoma, have been associated with psoriasis
-
Sun pain and solar dysesthesia: A new challenge in clinical practice Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-02-16 Piergiacomo Calzavara-Pinton, Francesco Tonon, Irene Calzavara-Pinton
A few patients report intense pain and other unpleasant sensations, such as burning, dysesthesia and hyperalgesia, after even brief exposure to the sun and in the absence of any skin lesion. Sometimes they also develop systemic symptoms, such as mild fever, fatigue, faintness and fainting. As a result, these patients carefully avoid even short-term sun exposure with a consequent severe negative impact
-
Characteristics of dermal vascularity in melasma and solar lentigo Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-02-14 Yusuke Hara, Takako Shibata
Melasma and solar lentigo (SL) are major benign hyperpigmented lesions, and both have been shown to involve the dermal vasculature. This review discusses current knowledge regarding the clinical characteristics of dermal vascularity in melasma and SL, as well as the results of relevant molecular biological investigations.
-
Cover Image Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-01-30 Yuki Enomoto, Yoshifumi Kanayama, Kyoko Ikumi, Mai Sakurai, Aya Yamamoto, Akimichi Morita
-
Photoprotective effects of Lithospermum erythrorhizon and Pueraria lobata extracts on UVB-induced photoaging: A study on skin barrier protection Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-01-26 Sungjin Lee, Sarang Oh, Qiwen Zheng, Shengdao Zheng, Myeongju Kim, Sejig Park, Wonmi Choi, Chang Shik Yin, Tae-Hoo Yi
Lithospermum erythrorhizon and Pueraria lobata exhibit promising potential as cosmetic additives for mitigating skin barrier impairment induced by photoaging. Despite their potential, the precise mechanisms underlying their protective and ameliorative effects remain elusive. This study sought to assess the reparative properties of Lithospermum erythrorhizon and Pueraria lobata extracts (LP) on UVB-irradiated
-
Clinical, histopathological and immunohistochemical evaluation of ultraviolet A1 treatment in early-stage mycosis fungoides Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-01-26 Nuray Keskin, Berkay Temel, Esra Adışen, Ahmet Burhan Aksakal, Elif Acar, Özlem Erdem
Mycosis fungoides (MF) is the most common variant of cutaneous T-cell lymphomas primarily involving the skin. Early-stage MF is characterised by non-specific skin lesions and non-diagnostic biopsies. While skin-focused treatments, such as PUVA and narrowband UVB (nbUVB), are the most frequently recommended treatments, the UVA1 efficacy has been researched in recent years. The purpose of this study
-
The correlation analysis between alterations of serum vitamin D, IL-33 levels, and clinical improvement after narrow-band UVB treatment in vitiligo patients: A case–control study Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-01-18 Emin Soyer, Berkay Temel, Neslihan Bukan, Canan Yilmaz Demirtas, Ayla Gulekon
The etiology of vitiligo has not been completely elucidated. Recently, 25-hydroxyvitamin D (25(OH)D) and IL-33 levels were found to be associated with the development of the vitiligo. The aim was to assess relationship between 25(OH)D, IL-33 levels, and clinical improvement after narrow-band UVB treatment in vitiligo.
-
The impact of phototherapy on itch intensity and itch-related quality of life amongst different skin diseases, skin phototypes and genders – A prospective study with 102 patients Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-01-19 Tamara Merkel, Alexander Navarini, Simon Mueller
Phototherapy is a mainstay to treat itchy conditions. However, only little is known about differences in the antipruritic effect of phototherapy amongst different skin conditions, phototypes and genders.
-
Cigarette smoking is an independent risk factor for developing vitiligo on the hands Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-01-17 Yuki Enomoto, Yoshifumi Kanayama, Kyoko Ikumi, Mai Sakurai, Aya Yamamoto, Akimichi Morita
Vitiligo presents with varying clinical features based on the type and location. Treatment tends to be more effective on the face, neck, trunk, and mid-extremities, while the lips and distal extremities may be more resistant. Vitiligo in frequently exposed areas such as the face, arms, legs, and hands is typically associated with a lower Dermatology Life Quality Index.
-
Photodynamic therapy in periodontitis: A narrative review Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-01-17 Min Nie, Peipei Zhang, Janak Lal Pathak, Xiaoyu Wang, Yafei Wu, Jingmei Yang, Yuqin Shen
Periodontitis, a chronic infectious disease, is primarily caused by a dysbiotic microbiome, leading to the destruction of tooth-supporting tissues and tooth loss. Photodynamic therapy (PDT), which combines excitation light with photosensitizers (PS) and oxygen to produce antibacterial reactive oxygen species, is emerging as a promising adjuvant treatment for periodontitis.
-
Posaconazole-induced phototoxic drug reaction: A case report Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-01-17 Rachel Rebecca Lin, David Alvarez Cespedes, Clara Milikowski, Scott Andrew Elman
CONFLICT OF INTEREST STATEMENT No authors have any conflicts of interest or disclosures to report.
-
Knowledge and the behavioral patterns of photoprotection among Koreans with skin disease Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-01-11 Seong Jin Jo, Seong Rae Kim, Si Hyung Lee, Young-Joon Seo, Hyo Hyun Ahn, Jong Hee Lee, Sang Ho Oh, Ki-Heon Jeong, Kui Young Park, Chul Hwan Bang, Min-Soo Kim, Jae Yoon Jung, Young Wook Ryoo, Sang Seok Kim, Dae Hun Suh
Photoprotection is crucial in preventing the development and progression of various skin diseases. However, patients with skin disease have limited awareness of photoprotection. We evaluated the knowledge and behavioral patterns of photoprotection among Koreans with skin diseases.
-
A triple combination of latanoprost, fractional CO2 laser, and platelet-rich plasma in localized vitiligo: A clinical and histopathologic study Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-01-10 Salma Samir Omar, Khaled Fawzy Elmulla, Rania Gaber Aly, Ahmed Elkaffas, Aliaa Ismail
Several treatment modalities are available for the treatment of vitiligo due to the lack of a uniformly effective therapy. Topical latanoprost 0.005% is an effective topical treatment. Fractional CO2 laser alone or combined with platelet-rich plasma (PRP) has been proposed as effective adjunctive therapies.
-
Objective assessment of color match for a universal tinted sunscreen on individuals with skin of color: A pilot study. Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2024-01-01 Indermeet Kohli,Marissa S Ceresnie,Fayven Teklehaimanot,Brittany N Lane,Richard H Huggins,Iltefat H Hamzavi,Henry W Lim,Tasneem F Mohammad
-
Skin cancer prevention in extreme sports: Intervention in a 24-h race Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2023-12-29 Alba Rodríguez Martínez, Carmen Vaz Pardal, José Aguilera Arjona, Francisco Rivas Ruiz, Diego Doncel Molinero, Manuel Ruiz Paulano, Andras Subert, Jose Vicente Gutiérrez Manzanedo, Jacobo Cambil Martín, Maria Victoria de Gálvez Aranda, Leocricia Jiménez López, Nuria Blázquez Sánchez, Magdalena de Troya Martín
Excessive sun exposure and sunburns are the main preventable causes of skin cancer. The growing popularity of outdoor sports in developed countries has motivated the objective of this work to study the risk of photoexposure and the skin cancer prevention needs of athletes in an extreme race and evaluate an intervention targeted at this population.
-
Evaluating the factors influencing sun protection factors (SPF): Pooling data from multiple studies involving two reference ISO 24444:2019 sunscreen products (P2 and P8) Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2023-12-29 Corinne Granger, Carles Trullàs, Nusayha Bibi Sokeechand, Eric Jourdan, Jean Krutmann, Veronique Francois-Newton, Muzzammil Hosenally
Standardized methods for sun protection factor (SPF) testing are still beset with endpoint and method-driven issues, and can be influenced by multiple factors. The purpose of this analysis is to explore the factors influencing the results of sun protection factor (SPF) testing in human subjects according to the ISO 24444:2019 standard. Intrinsic factors, such as baseline skin color, age and gender
-
A narrative review of the impact of ultraviolet radiation and sunscreen on the skin microbiome Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2023-12-30 Garett J. Grant, Indermeet Kohli, Tasneem F. Mohammad
The human skin microbiome is a dynamic ecosystem that plays an important role in skin health. The skin microbiome has been implicated in numerous diseases, and our knowledge surrounding it continues to evolve. A better understanding of the interactions between the environment and the skin microbiome will lead to improvements in skin health.
-
Skin cancer survivorship and sun protection behaviors in the United States Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2023-12-29 Daniela L. Domínguez Bueso, Liza M. González Ruiz, Lía I. Mondragón Márquez, Jason J. Liu
Skin cancer survivors are more vulnerable to subsequent skin cancers and other malignancies, but previous studies have not examined in detail their sun protection behavior prevalence by sociodemographic factors. We aimed to understand the sociodemographic disparities in the prevalence of three important types of sun protection behaviors: using sunscreen, seeking shade, and wearing protective clothing
-
Estimation of serum and tissue level of interleukin-15 (IL-15) and IL-15 receptor alpha (IL-15Rα) in mycosis fungoides before and after phototherapy: An interventional cohort study Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2023-12-29 Rania M Mogawer, Randa Youssef, Kholoud Helmy, Nourhan Emad, Olfat Shaker, Sarah Orabi
Mycosis fungoides (MF) is a chronic, highly recurrent cutaneous T-cell lymphoma, whose pathogenesis has not yet been fully elucidated. Interleukin-15 was previously highlighted as a viability factor for cutaneous T-cell lymphoma with previous studies shedding light on its role in pathogenesis of MF and its plausibility as a potential therapeutic target.
-
A focused review of visible light therapies for vitiligo Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2023-12-11 Mitchell J. Winkie, Goranit Sakunchotpanit, Carlos E. Salazar, Nicole S. Gunasekera, Elizabeth A. Buzney, Vinod E. Nambudiri
Vitiligo can be challenging to treat and exhibit an unpredictable clinical course. Phototherapy in the form of visible light can achieve both repigmentation and depigmentation outcomes in vitiligo, with minimal associated adverse events. This review focuses on the mechanistic understandings and clinical outcomes of visible light-based treatments for vitiligo.
-
Evaluation of the protection of sunscreen products against long wavelength ultraviolet A1 and visible light-induced biological effects Photodermatol. Photoimmunol. Photomed. (IF 2.5) Pub Date : 2023-12-08 Nneamaka Ezekwe, Aunna Pourang, Alexis B. Lyons, Shanthi Narla, Amruth Atyam, Shereen Zia, Ben J. Friedman, Iltefat H. Hamzavi, Henry W. Lim, Indermeet Kohli
Long wavelength ultraviolet-A1 in combination with visible light induces hyperpigmentation, particularly in dark-skin phototypes. This study evaluated the efficacy of four sunscreen formulations in protecting against VL + UVA1 (370–700 nm).